<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7129715\results\search\testTrace\results.xml">
  <result pre="is being made to develop an effective vaccine or prophylactic" exact="treatment" post="as soon as possible in order to manage the"/>
  <result pre="treatment as soon as possible in order to manage the" exact="infection" post="and prevent future epidemics [1], even after the two"/>
  <result pre="management strategies are aimed at reducing the transmission of the" exact="infection" post="and providing support for hospitalized patients. Various drugs have"/>
  <result pre="concerning the drugs that are currently being tested in the" exact="treatment" post="of COVID-19. We are old acquaintances of chloroquine, hydroxychloroquine,"/>
  <result pre="scientific community in the search for possible solutions to SARS-Cov2" exact="infection" post="[4]. 1 Anti-malarials As rheumatologists, we are aware of"/>
  <result pre="receptors. There have been some anecdotal reports of successful chloroquine" exact="treatment" post="from China, and the guidelines of the Italian Society"/>
  <result pre="trial of chloroquine found that it did not prevent influenza" exact="infection" post="[5]. 2 Tocilizumab/Sarilumab The clinical presentation of COVID-19 is"/>
  <result pre="including IL-6,. The acute respiratory distress syndrome induced by coronavirus" exact="infection" post="is associated with the over-exuberant release of cytokines (a"/>
  <result pre="a role for the Janus kinase inhibitor baricitinib in the" exact="treatment" post="of acute COVID-19 respiratory disease. Viruses infect cells by"/>
  <result pre="their possible adverse effects. The people most affected by SARS-CoV-2" exact="infection" post="are adults aged &amp;gt;60Ã‚ years with one or more"/>
  <result pre="gastrointestinal perforation [[10], [11], [12], [13], [14], [15], [16]]. Careful" exact="screening" post="is therefore necessary before starting any of these treatments,"/>
  <result pre="Exp Rheumatol3822020175180Mar-Apr32207680 5TouretF.de LamballerieX.Of Cloroquine and Covid 19Antiviral Res177202010476232147496 6XuX.HanM.LiT.SunW.WangD.FuB.Effective" exact="treatment" post="of severe COVID-19 patients with tocilizumabChinaXiv202003000262020 7http://www.news.sanofi.us/2020-03-16-Sanofi-and-Regeneron-begin-global-Kevzara-R-sarilumab-clinical-trial-program-in-patients-with-severe-COVID-19. Accessed 17"/>
  <result pre="human monoclonal 1 antibody blocking SARS-CoV-2 infectionBiorxiv20203202011.987958 9RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.Baricitinib as potential" exact="treatment" post="for 2019-nCoV acute respiratory diseaseLancet.395102232020 Feb 15e30e3132032529 10ArabiY.M.MandourahY.Al-HameedF.Saudi critical"/>
  <result pre="J Respir Crit Care Med1976201875776729161116 11LeeN.Allen ChanK.C.HuiD.S.Effects of early corticosteroid" exact="treatment" post="on plasma SARS-associated coronavirus RNA concentrations in adult patientsJ"/>
  <result pre="coronavirus RNA concentrations in adult patientsJ Clin Virol314200430430915494274 12FavalliE.G.IngegnoliF.De LuciaO.CincinelliG.CimazR.CaporaliR.COVID-19" exact="infection" post="and rheumatoid arthritis: faraway, so close!Autoimmun Rev202020 Mar102523 13CasoF.CostaL.RuscittiP.NavarinicL.Del"/>
  <result pre="predisposed subjects?Autoimmun Rev242020 Mar102524 14RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injuryLancet.39510223202047347532043983 15KalilA.C.SunJ.Low-dose steroids for septic shock"/>
 </snippets>
</snippetsTree>
